PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Essen

About this trial

There is a prospective risk-adapted evaluation of the optimal dose of radiotherapy for definitive radiotherapy of locally advanced small cell lung cancer within the corridor recommended as standard therapy according to the current interdisciplinary S3 guideline of the German Cancer Society/Cancer Aid/AWMF

Eligibility criteria

Qualifiers

Histopathologic confirmation

Limited disease

Disqualifiers

Other histology than small cell lung cancer

Further tumor diagnosis

ECOG 3 or worse

Extensive disease

Trial design

Treatments tested in this trial

  • PET based Raditherapy boost

Treatment groups

No treatment groups listed

Sponsors and collaborators